JAMES STANLEY: Open Payments
NPI 1568983195 · SOUTH WILLIAMSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$222 in 11 payments from 8 companies in 2025. Trend: 2023 $212 · 2024 $98 · 2025 $222
Food & beverage: $222
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $60 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Indivior Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: UBRELVY, TRELEGY ELLIPTA, CAPLYTA, VERQUVO, Ozempic, GVOKE HYPOPEN, SUBLOCADE, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
